These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24012293)

  • 1. Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis.
    Sarkar S; Schaefer M
    Psychosomatics; 2014; 55(3):221-34. PubMed ID: 24012293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing depression during hepatitis C treatment.
    Sockalingam S; Abbey SE
    Can J Psychiatry; 2009 Sep; 54(9):614-25. PubMed ID: 19751550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.
    Asnis GM; De La Garza R
    J Clin Gastroenterol; 2006 Apr; 40(4):322-35. PubMed ID: 16633105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
    Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
    J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis.
    Ehret M; Sobieraj DM
    Int J Clin Pract; 2014 Feb; 68(2):255-61. PubMed ID: 24372654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.
    Fialho R; Burridge A; Pereira M; Keller M; File A; Tibble J; Whale R
    Psychopharmacology (Berl); 2016 May; 233(9):1689-94. PubMed ID: 25971875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis C.
    Fábregas B; Moura A; Ávila R; Carmo R; Teixeira AL
    Braz J Psychiatry; 2014; 36(2):183. PubMed ID: 24839091
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.
    Udina M; Hidalgo D; Navinés R; Forns X; Solà R; Farré M; Capuron L; Vieta E; Martín-Santos R
    J Clin Psychiatry; 2014 Oct; 75(10):e1113-21. PubMed ID: 25373120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific serotonin reuptake inhibitors prevent interferon-α-induced depression in patients with hepatitis C: a meta-analysis.
    Jiang HY; Deng M; Zhang YH; Chen HZ; Chen Q; Ruan B
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1452-60.e3. PubMed ID: 23648373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine for the prevention of depression induced by high-dose interferon alfa.
    Musselman DL; Lawson DH; Gumnick JF; Manatunga AK; Penna S; Goodkin RS; Greiner K; Nemeroff CB; Miller AH
    N Engl J Med; 2001 Mar; 344(13):961-6. PubMed ID: 11274622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
    Schaefer M; Mauss S
    Curr Drug Abuse Rev; 2008 Jun; 1(2):177-87. PubMed ID: 19630716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials?
    Hou XJ; Xu JH; Wang J; Yu YY
    PLoS One; 2013; 8(10):e76799. PubMed ID: 24204676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial.
    Morasco BJ; Loftis JM; Indest DW; Ruimy S; Davison JW; Felker B; Hauser P
    Psychosomatics; 2010; 51(5):401-8. PubMed ID: 20833939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
    Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1091-9. PubMed ID: 12030950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.
    Loftis JM; Socherman RE; Howell CD; Whitehead AJ; Hill JA; Dominitz JA; Hauser P
    Neurosci Lett; 2004 Jul; 365(2):87-91. PubMed ID: 15245784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of depressive disorders after interferon-induced depression.
    Chiu WC; Su YP; Su KP; Chen PC
    Transl Psychiatry; 2017 Feb; 7(2):e1026. PubMed ID: 28170005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
    Schäfer A; Scheurlen M; Seufert J; Keicher C; Weissbrich B; Rieger P; Kraus MR
    J Hepatol; 2010 Jan; 52(1):10-5. PubMed ID: 19897271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-induced depression in chronic hepatitis C.
    Horsmans Y
    J Antimicrob Chemother; 2006 Oct; 58(4):711-3. PubMed ID: 16951413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.